1995 U.S. Tax Ct. LEXIS 50">*50 Decision will be entered under Rule 155.
This case concerns the proper tax treatment of investment bankers' fees and printing costs incurred by petitioner in response to a series of unsolicited (but eventually successful) offers to acquire petitioner's stock. Petitioner's board of directors rejected the first two offers made by the acquirer. Ultimately, however, the board unanimously (1) approved a plan of merger with the acquirer and (2) recommended the acquirer's third offer to shareholders. Petitioner claims that, since the takeover was hostile, this case is distinguishable from
105 T.C. 166">*167 HALPERN,
105 T.C. 166">*168 Unless otherwise indicated, all section references are to the Internal Revenue Code in effect for the year in issue, and all Rule references are to the Tax Court Rules of Practice and Procedure.
FINDINGS OF FACT
Some of the facts have been stipulated, and the stipulated facts are incorporated in our findings by this reference.
At the time the petition was filed, petitioner's principal office was located in Decatur, Illinois.
Petitioner, A.E. Staley Manufacturing Co. and Subsidiaries, was an affiliated group of corporations, formerly named Staley Continental, Inc. and Subsidiaries (SCI). The predecessor of both petitioner and SCI was A.E. Staley Manufacturing Co. (AES), which was incorporated in Delaware in 1906.
From its organization until November 1984, the primary business of AES consisted of storing and marketing corn and soybeans and of milling, processing, and refining corn and soybeans. Through a process called "corn wet milling", AES produced sweeteners, starches, oils, and other ingredients for the food and beverage industry. The principal product of1995 U.S. Tax Ct. LEXIS 50">*53 AES was high fructose corn syrup, which is a sweet syrup made from corn that can be used as a substitute for cane or beet sugar in food production and industrial applications. By the mid-1980's, high fructose corn syrup became the leading sweetener in the U.S. food and beverage market, especially in the soft drink industry. However, corn wet milling was a cyclical business, because it was dependent on the supply, price, and perishable nature of a single commodity, corn.
As of 1975, Donald E. Nordlund (Nordlund) was the chief executive officer and chairman of the board of AES. In 1984, the board of directors and management of AES made a long-term strategic decision to diversify into the food service business, which they believed had significant growth potential. AES sought growth opportunities in the food service business, because AES management believed that the high fructose corn syrup market was a mature market that had little growth opportunity and thought that earnings from the food service business would provide a hedge against the cyclical corn-based business. As part of this growth strategy, in 1984, 105 T.C. 166">*169 AES acquired CFS Continental, Inc. (CFS), a leading supplier to the food 1995 U.S. Tax Ct. LEXIS 50">*54 service industry.
AES reorganized in 1985 to emphasize the changes in the company and its new business strategy and, also, to consolidate the management of its corn wet milling business and food service businesses; SCI was formed and became the parent company of AES and CFS. SCI moved its corporate headquarters from Decatur to Rolling Meadows, Illinois, a suburb of Chicago. The objective of SCI was to modernize the corn wet milling plants to make them more efficient so as to reduce costs and to use the revenues from corn wet milling to pursue growth in the food service business. As part of this objective, SCI acquired Smelkinson Bros. Corp., a Baltimore-Washington food service distributor; Garden Products, Inc., a Portland produce distributor; Bit O'Gold, a Chicago food service distributor; the HAVI Corp. and Fresh Start Bakeries, suppliers to the McDonald's restaurant chain; Collins Foodservice, Inc.; Churchill, Inc., a Florida coffee roasting operation; Interstate Shortening; and Full Sail Products, Inc., a Los Angeles produce distributor. In 1986, SCI disposed of its soybean processing plants, because they no longer fit within the strategic plan of the company.
1995 U.S. Tax Ct. LEXIS 50">*55 Tate & Lyle PLC (Tate & Lyle), a publicly held United Kingdom corporation, was the largest refiner and distributor of sugar in the world. The chairman of the board of directors and chief executive officer of Tate & Lyle was Neil M. Shaw (Shaw). As of April 1988, Tate & Lyle was not involved in corn refining or the production of corn sweeteners, except for its interest in the Cereal Science and Technology Group (CST Group).
The CST Group consisted of Amylum N.V., a Belgian corporation, and Tunnel Refineries, Ltd., a United Kingdom corporation, and was involved in research and refining of starches, sweeteners, and related corn, wheat, and other small grain products. Tate & Lyle, SCI, and Compagnie Industrielle et Financiere des Produits Amylaces, S.A. (Compagnie Industrielle), a Belgian corporation, each owned 33.33 percent of the CST Group. Nordlund and Shaw were on 105 T.C. 166">*170 the board of directors of Amylum N.V. and of Tunnel Refineries, Ltd.
Sometime around 1986, SCI became concerned that it could become a potential target of a hostile takeover. Its concern stemmed in part from the mergers and acquisitions "climate" at that time and in part from actions allegedly1995 U.S. Tax Ct. LEXIS 50">*56 taken by Drexel Burnham Lambert, Inc. (Drexel). On February 19, 1987, SCI filed a complaint in the U.S. District Court for the Northern District of Illinois against Drexel, charging Drexel with extortion and securities fraud, in violation of the Federal Racketeer Influenced and Corrupt Organizations Act and with violations of the Securities Act of 1933. In its complaint, SCI alleged that, in the fall of 1986, it planned to make a public offering of new common stock to raise capital and that Drexel deliberately accumulated SCI stock and threatened to sabotage the stock offering unless SCI abandoned its offer and agreed to a leveraged buy-out of SCI that would be managed by Drexel.
SCI hired the law firm of Skadden, Arps, Slate, Meagher & Flom (Skadden Arps), which recommended that SCI adopt "antitakeover" devices. SCI adopted some antitakeover measures such as stockholder rights plans ("poison pills") and management retention agreements.
SCI also hired two investment banking firms, the First Boston Corp. (First Boston) on January 6, 1987, and Merrill Lynch Capital Markets (Merrill Lynch) on February 13, 1987. The retainer agreement with Merrill Lynch provided that Merrill Lynch was1995 U.S. Tax Ct. LEXIS 50">*57 retained as a "financial advisor" to SCI "in connection with certain merger or acquisition situations." Among other services, the Merrill Lynch retainer agreement provided that Merrill Lynch would provide (1) assistance in the evaluation of advance defensive preparations of SCI and (2) advice and assistance in the event that an unsolicited offer was threatened or initiated. The First Boston retainer agreement provided that First Boston would, among other things, assist SCI in defining merger and acquisition priorities. Merrill Lynch and First Boston were each paid a retainer fee of $ 75,000. Additionally, both agreements provided that Merrill Lynch and First Boston would 105 T.C. 166">*171 be retained to represent SCI if an offer were made for the acquisition of the stock or assets of SCI.
In March 1987, Merrill Lynch made presentations to the management and board of directors of SCI. Although no company was attempting to acquire SCI at that time, Merrill Lynch recommended a number of actions that SCI should take to prepare itself against potential unsolicited takeover attempts. SCI implemented many of these actions, including setting up a "defensive team" of lawyers, investment bankers, and SCI executives1995 U.S. Tax Ct. LEXIS 50">*58 who would be ready to respond quickly to any hostile bid; implementing a "stock watch program" to track the stock of SCI; strengthening the stock rights plan of the company; and studying the feasibility of a leveraged buy-out by management. Merrill Lynch also advised SCI that, if an unsolicited offer was made for SCI stock, the board of directors had a duty to "stop, look, and listen" and not to make any "hasty response" to that offer.
Merrill Lynch also recommended that SCI identify and seek friendly investors who could hold a blocking interest in SCI stock and act as "white knights" in the event that a raider threatened a hostile takeover of SCI. Tate & Lyle was considered a possible white knight in the event of a hostile takeover, and Nordlund and Shaw discussed the acquisition by Tate & Lyle of up to a 20-percent interest in SCI.
In April 1987, Tate & Lyle began purchasing SCI stock on the open market. In late June 1987, Robert B. Hoffman (Hoffman), the chief financial officer of SCI, contacted Tate & Lyle to determine whether Tate & Lyle would enter into a "standstill agreement" that would limit the amount of SCI stock that it would acquire. Tate & Lyle did not agree to a standstill1995 U.S. Tax Ct. LEXIS 50">*59 agreement at that time.
As of June 24, 1987, and August 13, 1987, Tate & Lyle owned approximately 4.37 percent and 4 percent, respectively, of the outstanding SCI common stock. Nordlund and Shaw casually discussed the possibility of initiating discussions about a merger between Tate & Lyle and SCI; however, no substantive merger discussions occurred. In October 1987, Nordlund directed Merrill Lynch to prepare an analysis of a combination of SCI and Tate & Lyle; that study concluded that a combination would dilute the value of SCI.
On November 11, 1987, Shaw sent a handwritten note to Nordlund to inform him that Tate & Lyle might buy more 105 T.C. 166">*172 shares in SCI and that Tate & Lyle was going to file a Hart-Scott-Rodino notification. Tate & Lyle filed a Hart-Scott-Rodino notification on November 18, 1987, to acquire up to 25 percent of SCI stock. SCI management was concerned that the Tate & Lyle Hart-Scott-Rodino filing would "put SCI into play", meaning that SCI would be put up for sale.
Members of the SCI defensive team met on November 22, 1987, in preparation for a meeting with Tate & Lyle. At a meeting on November 23, 1987, SCI told Tate & Lyle that it was concerned about the Tate & Lyle1995 U.S. Tax Ct. LEXIS 50">*60 Hart-Scott-Rodino filing and that SCI would oppose additional purchases of SCI stock by Tate & Lyle, unless Tate & Lyle executed a standstill agreement limiting its investment in SCI. Tate & Lyle refused to execute a standstill agreement and did not indicate whether it intended to purchase more SCI stock.
On December 14, 1987, SCI strengthened the terms of its stockholder rights plan by reducing from 40 percent to 20 percent the ownership percentage of the common stock of SCI that would trigger the "flip in" provision of the stock rights plan.
On April 8, 1988, Tate & Lyle, through one of its U.S. subsidiaries, RP Acquisition Corp. (RP Acquisition), made a public tender offer directly to SCI shareholders through advertisements in the New York Times and the Wall Street Journal. The Tate & Lyle offer was for cash for all outstanding shares at $ 32 per share of common stock and was set to expire at 12:00 midnight on May 5, 1988. The offer was, among other things, conditioned upon (1) the nullification of the SCI shareholder rights plan; (2) the invalidity or inapplicability of the restrictions on business combinations of
105 T.C. 166">*173 Tate & Lyle did not present any proposals to acquire all of the outstanding SCI stock to the management or board of directors of SCI prior to making the tender offer. The management, board of directors, and investment bankers of SCI considered the Tate & Lyle tender offer to be hostile, because Tate & Lyle made it directly to SCI shareholders without the knowledge, endorsement, or encouragement of the management or board of directors of SCI.
Shaw wrote a letter to Nordlund dated April 8, 1988, criticizing SCI management and explaining why Tate & Lyle was making the tender offer. This letter was published in the Tate & Lyle tender offer and stated that Nordlund had "led Staley [Continental, Inc.] away from its core business * * *, using cash generated1995 U.S. Tax Ct. LEXIS 50">*62 by that business to finance acquisitions and expansion in the food service distribution segment" to satisfy short-term goals and stated that Nordlund and SCI management had built a "web of entrenchment devices" to stay in office. Shaw's letter also stated that, if Tate & Lyle succeeded in acquiring control of SCI, it would immediately sell the food distribution subsidiary CFS.
Also on April 8, 1988, Tate & Lyle and RP Acquisition sued SCI in the Delaware Court of Chancery to enjoin the operation of the SCI shareholder rights plan and the use of other "antitakeover defenses"; in Federal District Court in Delaware, challenging the constitutionality of the Delaware antitakeover statute; and in South Carolina and Minnesota, seeking an injunction to avoid applicability of those States' antitakeover statutes.
In a letter to the Tate & Lyle shareholders, Shaw stated: Tate & Lyle's strategy is to develop its sweetener businesses worldwide. Staley is a leading US producer of corn sweeteners. The acquisition of Staley will establish Tate & Lyle as a major supplier of sweeteners to the US market, and the only one offering all three products--cane sugar, beet sugar and sweeteners derived1995 U.S. Tax Ct. LEXIS 50">*63 from corn. Taken with the development of sucralose, this acquisition will further enhance Tate & Lyle's position in the world sweetener industry. Tate & Lyle has had business contacts and relationships with Staley for more than 10 years. During the last year, Tate & Lyle has built up a stake of just under five per cent of the outstanding shares of Staley Common Stock and, from time to time, there have been discussions between Tate & Lyle and Staley in which Staley has, among other things, suggested Tate & Lyle should increase its investment in Staley. As a result of its own internal review, Tate & Lyle has decided that it is not in its interests to 105 T.C. 166">*174 remain a minority shareholder, but that it should initiate the Tender Offer, and I have written to the Chairman of Staley accordingly. Despite various take-over defenses that have been implemented by Staley, the Directors of Tate & Lyle expect that the Acquisition of Staley will succeed. At the same time as announcing the Tender Offer, Tate & Lyle is commencing litigation in the US which, among other things, challenges the take-over defenses that Staley has established, and in particular, the benefit package for Staley's senior management. 1995 U.S. Tax Ct. LEXIS 50">*64 In the event that any defensive litigation is initiated against Tate & Lyle, it expects to defend itself vigorously. Litigation is a commonplace feature of US tender offers.
The senior management and defense team of SCI held an emergency meeting on Saturday morning, April 9, 1988, to begin preparation of the response of SCI to the tender offer. The first reaction by SCI management to the tender offer was that the offer was inadequate and that a Tate & Lyle takeover would not be in the best interests of SCI, because Tate & Lyle "brought nothing to the table" in terms of capital, marketing, or research and development and, also, because Tate & Lyle would abandon the SCI long-term strategic plan of entering the food service business. No one at the April 9, 1988, meeting suggested that SCI should negotiate with Tate & Lyle, and, as of that date, SCI senior management wanted to defeat the tender offer.
However, SCI management understood that the board of directors had a duty to evaluate properly the merits of the tender offer and, on April 12, 1988, SCI hired First Boston and Merrill Lynch to advise it with respect to the Tate & Lyle tender offer. 1995 U.S. Tax Ct. LEXIS 50">*65 The April 12, 1988, retainer agreements provided that First Boston and Merrill Lynch would, among other things: (1) undertake, in consultation with members of management, a study and analysis of the business, operations, financial condition and prospects of the Company [SCI]; (2) assist the Company in evaluating any proposal to acquire the Company; (3) meet with your Board of Directors to discuss its position and any recommendation to stockholders concerning any proposal to acquire the Company as well as available strategic alternatives and their financial implications; (4) if requested, render an opinion with respect to the adequacy of the consideration offered in any proposal to acquire the Company; 105 T.C. 166">*175 (5) to the extent requested by the Company, seek to negotiate with any person making a proposal to acquire the Company; and (6) advise the Company in the event that the Company becomes engaged in a proxy contest.
SCI management realized that it could not wait until the board voted on the offer before beginning to prepare the SCI "defense"; therefore, the defense team immediately began to consider alternatives to the tender offer. Due to the time constraints of the tender offer, the investment bankers began to prepare for various potential actions, including recapitalization and leveraged buy-out studies and the preparation of prospectuslike documentation for prospective buyers (white knights), in the event the board found the offer inadequate.
On April 18, 1988, investment bankers from First Boston and Merrill Lynch made a presentation to the board showing that, on an after-tax basis, the per share value of SCI stock ranged from $ 35.83 to $ 43.57 and, thus, that the $ 32 per share tender offer was below the value that the investment bankers placed on1995 U.S. Tax Ct. LEXIS 50">*67 SCI. The investment bankers also discussed options that were available to SCI, including the sale of the corporation as a whole; the sale of a division; a recapitalization; a leveraged buy-out; placement of blocks of stock; a spin-off; a public offering; and commencing an offer for Tate & Lyle ("pac-man" defense).
On April 20, 1988, after being formally advised by First Boston and Merrill Lynch that the tender offer was inadequate from a financial point of view, the SCI board voted unanimously (with one director absent) to reject the Tate & Lyle tender offer and to advise the SCI shareholders to reject it. The SCI board also resolved that it was in the best interests of the corporation and the shareholders to-- 105 T.C. 166">*176 explore and investigate, with the advice and assistance of the Corporation's financial and legal advisors, the possibility, feasibility and desirability of a variety of alternative transactions, including without limitation, a financial restructuring or recapitalization of the Corporation (which might include, among other things, a substantial dividend or other distribution to shareholders of the Corporation or a self-tender offer for or other repurchase of securities1995 U.S. Tax Ct. LEXIS 50">*68 of the Corporation), the sale of equity or other securities of the Corporation to a third party, the sale of the entire Corporation or one or both of its principal business segments to a third party (as part of the liquidation of the Corporation or otherwise), a joint venture between the Corporation and one or more other companies and a possible leveraged buy-out, the initiation and consummation of any of which may depend upon future developments, including future actions of Tate & Lyle and RP [Acquisition], with respect to the Tate & Lyle Offer * * *
As part of this effort, First Boston and Merrill Lynch held discussions with numerous domestic and foreign corporations and investors who they thought might be interested in acquiring all or part of SCI ("white knights" or "white squires") or in providing loans for recapitalization. First Boston and Merrill Lynch also prepared a confidential selling book called a "Descriptive Memorandum" that contained detailed information about SCI that would interest prospective buyers. These selling books were distributed to many interested parties, including Kohlberg, Kravis, Roberts & Co.SCI management also spoke directly with several companies1995 U.S. Tax Ct. LEXIS 50">*69 that were identified as potential white knights. Additionally, Merrill Lynch retained counsel in the United Kingdom to investigate whether a class of Tate & Lyle preferred stock existed that SCI could purchase and use to block the Tate & Lyle tender offer.
On April 21, 1988, SCI filed a form 14D-9, Solicitation/Recommendation Statement Pursuant to Section 14(d)(4) of the Securities Exchange Act of 1934, with the Securities and Exchange Commission (SEC), recommending that SCI shareholders not tender shares and explaining that the SCI board of directors opposed the tender offer.
Without solicitation from SCI, on April 29, 1988, Tate & Lyle increased its all-cash offer for SCI common stock from $ 32 per share to $ 35 per share. The SCI board of directors met on May 2, 1988, and unanimously determined that the revised Tate & Lyle offer of $ 35 per share was inadequate, 105 T.C. 166">*177 was not in the best interests of SCI and its shareholders, and should be rejected. The board of directors also resolved that it was "desirable and in the best interests of the Corporation and its shareholders to continue to explore and investigate, with the advice and assistance of1995 U.S. Tax Ct. LEXIS 50">*70 the Corporation's financial and legal advisors, the possibility, feasibility and desirability of a variety of alternative transactions". On May 3, 1988, SCI filed a form 14D-9 with the SEC and urged its shareholders to reject the revised tender offer. First Boston and Merrill Lynch continued to search for alternatives to the revised tender offer.
A May 5, 1988, Merrill Lynch interoffice memorandum pertaining to a potential recapitalization of SCI stated: Merrill Lynch Capital Markets ("ML") and The First Boston Corporation ("FOB") have been retained by the Board of Directors of Staley Continental, Inc. ("Staley" or the "Company") in its
On May 9, 1988, the Delaware Court of Chancery issued an opinion in the Tate & Lyle and RP Acquisition injunction action that denied a preliminary injunction enjoining the use of the SCI stockholder rights plan. The Court of Chancery stated that "a valid purpose for a stockholder rights plan (poison pill) is to promote an auction of the corporation." The Board has expressed both in oral argument and to the financial press, their desire to search and find a possible "white knight" or to seek leveraged buy-out financing. At this point, while the market price is greater than the tender price, the rights plan is obviously serving a useful purpose in allowing the Board to seek a more realistic offer. To do otherwise could conceivably subject the Board to actions predicated upon their failure to earnestly seek the highest bidder. * * *
Also on May 9, 1988, the U.S. District Court for the District of Delaware denied the RP Acquisition Corp. motion for preliminary injunction with respect to the Delaware antitakeover statute and rejected the Tate & Lyle (RP Acquisition) contentions concerning the unconstitutionality of the statute.
105 T.C. 166">*178 On or about May 10, 1988, First Boston and Merrill Lynch informed SCI that they were unable to find an alternative to the tender offer that would persuade shareholders not to sell their stock to Tate & Lyle. At this point, 1995 U.S. Tax Ct. LEXIS 50">*72 the SCI board of directors realized that it was unable to offer SCI shareholders an alternative that would create value for SCI shareholders greater than the price that Tate & Lyle was offering for the stock. SCI management directed the attorneys to engage in negotiations with Tate & Lyle, and SCI management instructed First Boston and Merrill Lynch to continue to look for alternatives to the tender offer.
On May 13, 1988, SCI, Tate & Lyle, and RP Acquisition entered into an Agreement and Plan of Merger, pursuant to which Tate & Lyle agreed to increase the consideration offered for the shares of common stock to $ 36.50 per share in cash. In a board of directors meeting on May 13, 1988, the investment bankers advised the directors that the $ 36.50 per common share was a fair offer for SCI shareholders. The investment bankers were able to reach this determination quickly, because they had already determined the range of fair per share values in connection with their evaluation of the Tate & Lyle offer and of the alternatives. Although the investment bankers continued to seek alternatives to the tender offer until minutes prior to the May 13, 1988, board of directors meeting, they advised1995 U.S. Tax Ct. LEXIS 50">*73 the directors that none of the more than 50 potential buyers that had been contacted expressed a serious interest in acquiring SCI at a price competitive with the Tate & Lyle offer. The investment bankers also advised the directors that options such as a recapitalization or leveraged buy-out were not realistic alternatives. The minutes from the May 13, 1988, board of directors meeting disclose that the board determined that the $ 36.50 per common share offer was "fair to and in the best interests of the holders of the Shares and hereby recommends that the shareholders of the Corporation accept the Revised Offer and vote for approval and adoption of the Merger Agreement, if necessary to effect the Merger".
In a May 16, 1988, letter to the shareholders, Nordlund stated: Your Board of Directors has unanimously approved and adopted the Merger Agreement, determined that the second revised Tate & Lyle offer 105 T.C. 166">*179 is fair to and in the best interests of shareholders of Staley Continental, and recommends that shareholders accept the second revised Tate & Lyle offer and tender all their Staley Continental shares pursuant thereto. In arriving at its decision, your Board of Directors gave careful1995 U.S. Tax Ct. LEXIS 50">*74 consideration to a number of factors described in the attached Schedule 14D-9 that is being filed today with the Securities and Exchange Commission. Among other things, your Board considered the opinion of its financial advisors, Merrill Lynch Capital Markets and The First Boston Corporation, that the second revised Tate & Lyle offer is fair from a financial point of view to Staley Continental shareholders.
Tate & Lyle lent approximately $ 1.34 billion to its wholly owned U.S. subsidiary, Tate & Lyle, Inc. Tate & Lyle, Inc., in turn, lent RP Acquisition, which was incorporated on March 22, 1988, for the purpose of the SCI acquisition, approximately $ 1.34 billion. RP Acquisition also borrowed $ 113 million from Tate & Lyle International Finance, a wholly owned subsidiary of Tate & Lyle. RP Acquisition used the proceeds of these loans to acquire virtually all of the outstanding shares of SCI on May 31, 1988. RP Acquisition and SCI then merged, effective June 2, 1988, and Tate & Lyle held 100 percent of the stock of SCI. SCI was the surviving corporation of the merger and, as a result, succeeded to the indebtedness that RP Acquisition owed1995 U.S. Tax Ct. LEXIS 50">*75 to Tate & Lyle, Inc., and Tate & Lyle International Finance.
Immediately after the merger, Tate & Lyle replaced the SCI senior management, including the chairman and chief executive officer, Nordlund; vice chairmen, Robert H. Cohn and Alvin W. Cohn; chief financial officer, Hoffman; executive vice president, R.E. Rocque; senior vice president for law and secretary of the board, Robert K. Scott; treasurer and vice president, Leland B. Miller; comptroller and vice president, Robert Agostinelli; controller and vice president, M.W. Urbut; and vice president for corporate relations, David Satterfield. During the 4 months after the takeover, Tate & Lyle also fired, and did not rehire, approximately 104 executives. In addition, Tate & Lyle closed the SCI Rolling Meadows headquarters, fired the clerical staff, and moved the executive offices to Decatur. Further, the entire board of directors resigned immediately after the acquisition occurred, with the exception of two directors, who resigned no later than June 8, 1988.
105 T.C. 166">*180 On June 6, 1988, Tate & Lyle announced that SCI reached an agreement to sell CFS to SYSCO Corp. (SYSCO); the terms of the agreement were amended on August 1, 1988, and provided1995 U.S. Tax Ct. LEXIS 50">*76 that SCI agreed to sell CFS to SYSCO for approximately $ 665 million in cash plus the assumption by SYSCO of approximately $ 50 million of debt. SCI used the proceeds of the CFS sale to repay a portion of the debt owed to Tate & Lyle, Inc., and to Tate & Lyle International Finance.
Effective September 30, 1988, Tate & Lyle changed the name of what remained of SCI to A.E. Staley Manufacturing Co.
SCI paid $ 23,052,914 to law firms, investment bankers, and other vendors for services in connection with the SCI response to the Tate & Lyle tender offer, all of which it deducted on its short-year return for the period ended May 31, 1988. This amount included $ 6,238,109 that was paid to First Boston; $ 6,272,593 that was paid to Merrill Lynch; and $ 165,318 that was paid to Charles P. Young, a printing company that printed, bound, and mailed forms 14D-9 and other communications that were sent to SCI shareholders between April 22 and May 16, 1988.
Among other adjustments, respondent disallowed deductions for all of the fees paid to First Boston and Merrill Lynch and disallowed $ 50,000 of the $ 165,318 that was paid to Chas. P. Young.
OPINION
I.
1995 U.S. Tax Ct. LEXIS 50">*77 This case concerns the proper tax treatment of investment bankers' fees and printing costs incurred by SCI in response to a series of unsolicited offers made by Tate & Lyle to acquire the outstanding stock of SCI. Tate & Lyle's first two offers were rejected. Ultimately, however, the SCI board of directors unanimously (1) approved a plan of merger with Tate & Lyle and (2) recommended Tate & Lyle's third offer to shareholders. Tate & Lyle then acquired SCI. Petitioner claims that, since the Tate & Lyle takeover was hostile, this case is distinguishable from
II.
We will not here repeat our findings of fact, 1 but will emphasize certain salient findings concerning the period beginning April 8, 1988, the date on which Tate & Lyle tendered $ 32 a share to the SCI shareholders, and ending shortly after May 31, 1988, when Tate & Lyle acquired SCI for $ 36.50 a share.
On April 12, 1988, SCI hired First Boston and Merrill Lynch (sometimes "the investment bankers") to advise it with respect to the Tate & Lyle tender offer. Both First Boston and Merrill Lynch were to be compensated by (1) a fixed fee, (2) contingent compensation if (A) Tate & Lyle or some other party acquired at least 50 percent of SCI's common stock or (B) SCI effected a recapitalization, and (3) future fixed fees if no contingent compensation were paid under (2).
On April 20, 1988, having been advised by the investment bankers that the Tate & Lyle offer of $ 32 was1995 U.S. Tax Ct. LEXIS 50">*79 too low, the SCI board of directors (sometimes "the board") voted to reject the offer and to advise shareholders to do the same. The board also resolved to explore alternatives to an acquisition by Tate & Lyle. At the direction of the board, the investment bankers contacted parties that might have been interested in acquiring all or part of SCI or in providing loans for a recapitalization. On April 29, 1988, Tate & Lyle increased its offer to $ 35. That offer also was rejected by the board. The investment bankers continued to search for alternatives. By about May 10, 1988, the investment bankers admitted defeat in their search for alternatives. SCI's management opened negotiations with Tate & Lyle, although the investment bankers were instructed to continue their search. On May 13, 105 T.C. 166">*182 1988, Tate & Lyle increased its offer to $ 36.50. The investment bankers advised the board that that was a fair offer for SCI shareholders. The board resolved to recommend to shareholders that they accept the $ 36.50 offer and approve and adopt any agreement necessary to effect a merger pursuant to Tate & Lyle's plan. On May 31, 1988, RP Acquisition, an indirect subsidiary of Tate & Lyle, acquired virtually1995 U.S. Tax Ct. LEXIS 50">*80 all of the outstanding shares of SCI at $ 36.50 a share. Following a reverse merger of RP Acquisition into SCI, SCI became a wholly owned, indirect subsidiary of Tate & Lyle.
For services rendered in connection with the Tate & Lyle tender offer (and for reimbursement of expenses), SCI paid $ 6,238,109 to First Boston and $ 6,272,593 to Merrill Lynch, all of which it deducted on its Federal income tax return. 2 SCI also paid and deducted printing costs of $ 165,318 ($ 50,000 of which are in controversy here).
As a result of the Tate & Lyle acquisition, the board resigned, senior management was replaced, many other1995 U.S. Tax Ct. LEXIS 50">*81 executives were fired, offices were closed, and parts of the company were sold. SCI's name was changed back to A.E. Staley Manufacturing Company, reflecting Tate & Lyle's decision to return SCI to its original business.
III.
It is clear that the board did not at first welcome the approach of Tate & Lyle. SCI's senior management saw Tate & Lyle's offer of $ 32 a share as (1) financially inadequate to SCI's shareholders and (2) not in the best interests of SCI itself. On the latter score, management thought that Tate & Lyle "brought nothing to the table" and would abandon management's long-term strategic plan for the corporation. The board rejected Tate & Lyle's first two offers. Eventually, however, the board unanimously recommended to shareholders that they accept a revised offer of $ 36.50 a share as "fair" and in their "best interest". Also, the board unanimously voted to approve a plan of merger with Tate & Lyle. Management's 105 T.C. 166">*183 fears with regard to SCI's long-term strategic plan were realized. Immediately after the acquisition, SCI sold CFS, thereby, in effect, canceling SCI's plan to diversify into the food service1995 U.S. Tax Ct. LEXIS 50">*82 business. Before the acquisition, Neil M. Shaw, chairman of the board of directors of Tate & Lyle and its chief executive officer, had announced his dissatisfaction with the direction in which SCI's management had taken SCI and his intention to return SCI to its core business. Tate & Lyle continued to operate the core business (principally sweeteners) of SCI.
Positive consequences of a nonoperational nature resulting to SCI from the acquisition include a consolidation of stock ownership and relief from shareholder-related expenses and duties.
The shareholders of SCI received $ 36.50 a share from Tate & Lyle. The fees paid the investment bankers pursuant to the April 12 retainer agreements necessarily benefited the shareholders of SCI by helping them obtain a price for their shares higher than the $ 32 a share initially offered by Tate & Lyle. 3
1995 U.S. Tax Ct. LEXIS 50">*83 105 T.C. 166">*184 IV.
A.
B.
In
C.
Our decision in 105 T.C. 166">*185 Although the mere presence of an incidental future benefit--" Courts long have recognized that expenses such as these, "'incurred for the purpose of changing the corporate structure for the benefit of future operations are not ordinary and necessary business expenses.'"
105 T.C. 166">*186 D.
In
E.
In
V.
A.
Petitioner recognizes similarities between its position and that of the taxpayers in 105 T.C. 166">*187 The critical factual distinction between this case and
Respondent argues that this case is not meaningfully distinguishable from As a result of the merger between Tate & Lyle and the petitioner, benefits accrued to the petitioner which were of an indefinite or long term duration. The expenditures are thus in the nature of capital expenditures and are not deductible under
B.
1.
Both parties focus on the actions of SCI's board in the period leading up to the merger. Respondent argues: Petitioner's board of directors had a fiduciary duty under Delaware law to act upon1995 U.S. Tax Ct. LEXIS 50">*90 the Tate & Lyle tender offer in a fully informed manner and to obtain for the petitioner's stockholders the maximum value for their stock. The investment bankers' fees and the printing costs were incurred by the petitioner's board of directors pursuant to that fiduciary duty; they were not incurred to defeat the Tate & Lyle tender offer or to preserve incumbent management's business policies. [Underscored in original.] SCI hired its investment bankers in response to the threat Tate & Lyle's hostile tender offer posed to SCI's business and in an effort to protect SCI's corporate enterprise. SCI's board believed Tate & Lyle brought nothing to the table and the board knew that if Tate & Lyle's takeover was successful, Tate & Lyle would breakup [sic] the business SCI has worked so hard to build.
105 T.C. 166">*188 2.
It is basic to the law of Delaware that a corporation functions for the benefit of its shareholders under the management of its board of directors.
In This entails an analysis by the directors of the nature of the takeover bid and its effect on the corporate enterprise. Examples of such concerns may include: inadequacy of the price offered, nature and timing of the offer, questions of illegality, the impact on "constituencies" other than shareholders (i.e., creditors, customers, employees, and perhaps even1995 U.S. Tax Ct. LEXIS 50">*93 the community 105 T.C. 166">*189 generally), the risk of nonconsummation, and the quality of securities being offered in the exchange. * * * [
In
while concern for various corporate constituencies is proper when addressing a takeover threat, that principle is limited by the requirement that there be
The court next addressed defensive measures (including a "poison pill", or rights, plan) adopted by the board and directed against the unwanted suitor, Pantry Pride. The court stated: In adopting the Plan, the To that extent the board acted in good faith1995 U.S. Tax Ct. LEXIS 50">*94 and upon reasonable investigation. Under the circumstances it cannot be said that the Rights Plan as employed was unreasonable, considering the threat posed.
Once the bidding exceeded the intrinsic value of the company, the situation changed: However, when Pantry Pride increased its offer to $ 50 per share, and then to $ 53, it became apparent to all that the break-up of the company was inevitable. The Revlon board's authorization permitting management to negotiate a merger or buyout with a third party was a recognition that the company1995 U.S. Tax Ct. LEXIS 50">*95 was for sale. The duty of the board had thus changed from the preservation of Revlon as a corporate entity to the maximization of the company's value at a sale for the stockholders' benefit. This significantly altered the board's responsibilities under the
3.
There is no disagreement between the parties as to Delaware law, nor is there serious disagreement between them with regard to the propriety of the SCI board's actions in response to the Tate & Lyle offers. In the end, the board recommended a Tate & Lyle offer of $ 36.50 to SCI's shareholders. Nevertheless, petitioner characterizes Tate & Lyle's takeover as hostile. By hostile, petitioner means that Tate & Lyle undertook its takeover without the approval or cooperation of SCI's management1995 U.S. Tax Ct. LEXIS 50">*96 or board of directors. Indeed, the SCI board rejected the first two offers made by Tate & Lyle. With regard to the second offer, the board determined not only that the offer was inadequate from a financial point of view but also that it was not in the best interests of SCI and its shareholders. Apparently, the board took into consideration the interests of corporate constituencies other than shareholders. There was reason for the board to be concerned on account of those constituencies: Neil M. Shaw, chairman of the board of Tate & Lyle and it chief executive officer, had announced his dissatisfaction with SCI's management and his intention to return SCI to its core business. Nevertheless, when Tate & Lyle's offer was raised to $ 36.50, the board unanimously (1) approved a plan of merger with Tate & Lyle and (2) recommended that offer to shareholders. At that price, the board had to subordinate its concern for corporate constituencies other than shareholders to the interests of shareholders. That is because, as made plain in
It is within that context of State law rules that we must decide whether, for Federal income tax purposes, the investment bankers' fees and printing expenses are deductible.
C.
The primary context for our analysis is
D.
For an expenditure to be deductible under
In It is true that "the line between shareholder benefit and corporate benefit is not always clear * * * "But this does not mean that where the primary or dominant motivation for a distribution was to benefit the stockholder 105 T.C. 166">*192 rather than the corporation that the articulation of a concededly subordinate business justification should cause the entire transaction to be recharacterized for tax purposes. To permit such a swallowing up of the greater by the lesser would require us to espouse a rule of law which both ignores the substance of corporate transactions and sharply departs from the recent trend of cases * * *. We decline to so rule. * * * [
Nevertheless, a corporate expenditure that benefits
In the statutory notice of deficiency upon which this case is based, respondent explained her disallowance of petitioner's deductions of the investment bankers' fees and printing costs in question as follows: "It has
E.
1.
The inquiry as to whether an expenditure may be deducted under
The primary effect of characterizing a payment as either a business expense or a capital expenditure concerns the timing of the taxpayer's cost recovery: While business expenses are currently deductible, a capital expenditure usually is amortized and depreciated over the life of the relevant asset, 1995 U.S. Tax Ct. LEXIS 50">*103 or, where no specific asset or useful life can be ascertained, is deducted upon dissolution of the enterprise. See
2.
The inquiry as to whether an expenditure may be deducted or must be capitalized is fact specific. The general nature of that inquiry is concisely described in 6 Mertens, Law of Federal Income Taxation, sec 25.37, at 118 (March 1992 rev.): Assuming that the expenditure is ordinary and necessary in the operation of the taxpayer's business, the answer to the question of whether the 105 T.C. 166">*194 expenditure is a deduction allowable as a business expense must be determined from the nature of the expenditure itself which in turn depends on the extent and permanence of the work accomplished by the expenditure. * * * [Fn. ref. omitted.]
To determine whether the expenditures in question are presently deductible, petitioner asks us to consider the motivation of SCI in hiring the investment bankers: "SCI hired its investment bankers in response to the threat Tate & Lyle's hostile tender offer posed to SCI's business and in an effort to protect SCI's corporate enterprise." In The dominant aspect of the transaction was not the fiduciary duty. Instead, the dominant aspect was the transfer of petitioner's stock for the benefit of petitioner and1995 U.S. Tax Ct. LEXIS 50">*105 its shareholders. We would let the tail wag the dog if we were to view the stock transfer as the incidental aspect and the fiduciary duty that arose from the stock transfer as the dominant aspect. [
If the purpose of the relevant Code provisions is to match expense with income, the directors' subjective reasons for making the expenditure are not significant to the analysis. Thus, presumably, under the "well established rule" recognized by the Supreme Court in
3.
In the companion cases of
F.
In The rationale behind these decisions appears to us to be that the purpose for which the expenditure is made has to do with the corporation's operations and betterment, sometimes with a continuing capital asset, for the duration of its existence or for the indefinite future or for a time somewhat longer than the current taxable year, in contrast to being devoted to the income production or other needs of the more immediate present. * * * [
Tate & Lyle's acquisition of SCI clearly was expected1995 U.S. Tax Ct. LEXIS 50">*110 by SCI's board to affect SCI's operations and betterment for the indefinite future. Neil M. Shaw, the chairman of the board of directors and chief executive officer of Tate & Lyle, had openly criticized SCI for moving away from its core business 105 T.C. 166">*197 and had announced his plan immediately to sell the food distribution subsidiary of SCI. Moreover, this is not the case of Tate & Lyle having
The expenditures in question--investment bankers' fees and printing costs--were made in connection with the change in ownership. The investment bankers' fees, in particular, were expended to receive an evaluation of Tate & Lyle's offers, to find alternatives thereto (which alternatives included financial restructuring and recapitalization, or a sale of the corporation), and for other advice. Indeed, all but approximately $ 1 million of the $ 12.5 million in fees and expenses paid to the investment bankers was based on the fact that Tate & Lyle acquired more than 50 percent of SCI's common stock. No doubt based in part on the investment bankers' evaluation and advice, the SCI board ultimately accepted the third Tate & Lyle offer, which admittedly had extended consequences for the operations of SCI. SCI also obtained certain shareholder-related benefits that the Supreme Court, in
What of the fact that petitioner characterizes the Tate & Lyle takeover as hostile? Clearly, the acquisition meant a strategic change for SCI, and, just as clearly, it would affect negatively certain corporate constituencies important to the board. Nevertheless, in the end, the board agreed to an acquisition by Tate & Lyle. Whatever duty the board owed to corporate constituencies other than the shareholders of SCI was discharged when the board agreed to the acquisition. In
G.
In
H.
For the reasons stated, no deduction is allowed under
I.
Petitioner argues that (1) all of the investment bankers' efforts were directed toward defeating Tate & Lyle's offer, (2) the investment bankers investigated plans that, if successful, would have required capitalization of their fees, (3) all of the investment bankers' work was abandoned when the board decided1995 U.S. Tax Ct. LEXIS 50">*116 to accept a Tate & Lyle offer, and (4) thus, SCI is entitled to deduct its expenditures with regard to its abandoned plans as a loss pursuant to 105 T.C. 166">*200 The courts and the I.R.S. recognize that where a plan of reorganization or a public offering is abandoned, the expenditures related to the proposed plan are deductible in the year the plan is abandoned.
No doubt petitioner is correct in its statement of the law. E.g.,
VI.
In
Reviewed by the Court.
HAMBLEN, SWIFT, GERBER, WRIGHT, PARR, WELLS, RUWE, WHALEN, COLVIN, and BEGHE,
FOLEY,
BEGHE,
1995 U.S. Tax Ct. LEXIS 50">*120 As a preliminary matter, I disagree with Judge Cohen's conclusion that the majority has adopted a "more stringent rule" than the rule applied in
The keys to the majority's opinion requiring capitalization are its findings that neither the investment bankers' fees nor the printing costs related to current income production or needs: "Those fees were incurred in connection with a change in ownership with indefinite and extended future consequences to SCI. They are properly matched against revenues of a taxable period (perhaps an indefinite taxable period) longer than the taxable year during which such fees were incurred." Majority op. pp. 46-47. Although it would be a rare change in corporate ownership that does not have indefinite and extended future consequences, the majority's inquiry is consistent with the Supreme Court's observation in
Even if I agreed with the dissenters' conclusion that the investment bankers' fees produced no long-term benefit to SCI, the facts of this case 2 as well as the inherent facts of corporate life in corporate takeover bids 3 would require the conclusion that some part of the advice of the investment1995 U.S. Tax Ct. LEXIS 50">*122 bankers produced a benefit to the shareholders of SCI by 105 T.C. 166">*203 helping them obtain a higher price for their shares than Tate & Lyle's initial offering price. As a result, this case could have been decided by dealing with the prior issue encompassed by the language of the statutory notice, "It has
1995 U.S. Tax Ct. LEXIS 50">*123 The parties did not try or argue this case on the theory of shareholder benefit, although that theory was put in play by the statutory notice. In appropriate future cases, that theory might justify an allocation between nondeductible fees for services that benefit the shareholders of the target by helping them obtain a higher price for their shares and some portion allocable to services in aid of an unsuccessful defense that arguably turn out to be of no benefit to anyone other than the service providers who received the fees.
Judge Cohen argues that the majority's conclusion--and I agree with that conclusion--that the investment bankers' services for which the fees were paid necessarily benefited the SCI shareholders by helping them obtain a higher price for their shares confuses the simple sequence of events with a cause and effect relationship. Cohen,
The causal relationship is clear. The advice of the investment bankers justified the SCI board's rejection of the initial Tate & Lyle offer and made 1995 U.S. Tax Ct. LEXIS 50">*125 it necessary for Tate & Lyle to raise its offer to an amount that was within the range of values determined by the investment bankers. The investment bankers' advice benefited the SCI shareholders by helping them obtain a higher price for their shares.
The question of shareholder benefit was also kept in play by the parties' disagreement--expressed in their briefs and addressed by the dissent--over when the directors' fiduciary duty under
The investment bankers earned their fees by providing advice that served interrelated functions that permitted the SCI directors to satisfy their fiduciary duties1995 U.S. Tax Ct. LEXIS 50">*126 to the corporation and its shareholders. See
As disclosed by the majority's recital of the facts and the observations of the commentators cited above, 5 the shareholder benefit theory is an appropriate rationale for disallowing the target's expenditures incurred in defending itself against an initially hostile takeover attempt. The opinion of the Delaware Supreme Court in
The dissenters have uncritically accepted petitioner's argument that the corporate propriety of engaging the investment bankers and attorneys to defend against a takeover bid requires that all their fees and disbursements be deductible as ordinary and necessary business expenses. This argument equates the propriety of incurring the costs with their deductibility as ordinary and necessary expenses. Apparently, this is on the theory that the costs are an integral part of SCI's appropriate initial response to the hostile offer, which includes the defense of the target's current business and business plan. In my view, the bulk of the fees incurred by the target are nondeductible because their unavoidable effect is to benefit the shareholders. This is so even though they were initially incurred as part of an appropriate corporate response to a hostile offer, and without regard to the corporate 105 T.C. 166">*206 propriety of the purpose that actuated1995 U.S. Tax Ct. LEXIS 50">*129 the directors in incurring them.
This case can be analyzed in terms of the traditional distinctions about primary versus incidental purposes and effects of the expenditures in dispute. A subordinate or incidental corporate business purpose will not control where the primary purpose of the expenditure is to benefit the shareholders, resulting in a dividend taxable to them.
The taxpayer in 105 T.C. 166">*207 Though the evidence was not precise on the relative costs incurred for business and pleasure use, we are satisfied that at least one-half of the expense was an ordinary and necessary expense of petitioner's business, and accordingly we allow the sum of $ 8,776.67 as a deduction [$ 17,543.35 having been disallowed by the Commissioner]. [
The case stands for the proposition that, even though corporate business judgment is properly exercised in incurring the expense, there is still a basis for making an allocation between deductible business purpose and nondeductible shareholder personal purpose on the basis of the actual benefits given and received. 7
1995 U.S. Tax Ct. LEXIS 50">*132 Under this approach, we would have no occasion, much less any need, to decide whether the nondeductible fees of SCI would have properly been includable in the income of the SCI shareholders as a dividend. Putting aside the administrative and other difficulties of pursuing the income inclusion of any such fees against the shareholders of a public company, the questions of corporate disallowance/shareholder inclusion can properly be decoupled where the corporate expenditures had substantial corporate business purposes as well as directly benefited the shareholders in their capacities as potential and actual sellers of their stock. 81995 U.S. Tax Ct. LEXIS 50">*133 In any event, the former SCI shareholders are not before us, and in all likelihood respondent did not determine any dividend tax deficiencies against them. 9
1995 U.S. Tax Ct. LEXIS 50">*134 105 T.C. 166">*208 Finally,
At issue were the contractually committed breakup fees paid in two separate transactions by Allied Stores and Federated Department Stores, respectively, to "white knights" in the1995 U.S. Tax Ct. LEXIS 50">*135 aftermath of their highly leveraged acquisitions by Robert Campeau. Soon after Allied and Federated were acquired, they went into bankruptcy because they could not sustain the debt burdens imposed on them to finance the acquisitions. The evident sympathies of the Bankruptcy Judge and the District Court Judge for these hapless debtors, and the obvious lack of "synergy" between the acquiror and his targets, are clear.
In the Allied/Federated situations, the expenses were held deductible under
SWIFT, WELLS, and VASQUEZ,
The following chart shows the closing price of Staley Continental, Inc. common stock on the New York Stock Exchange between Mar. 1, 1988, and June 7, 1988:
Date | Closing Price | Date | Closing Price |
Mar. 1 | 23.875 | Apr. 20 | 36.375 |
Mar. 2 | 23.750 | Apr. 21 | 37.250 |
Mar. 3 | 24.125 | Apr. 22 | 37.000 |
Mar. 4 | 24.250 | Apr. 25 | 36.500 |
Mar. 7 | 23.750 | Apr. 26 | 36.500 |
Mar. 8 | 24.125 | Apr. 27 | 37.000 |
Mar. 9 | 25.000 | Apr. 28 | 37.875 |
Mar. 10 | 24.875 | Apr. 29 | 38.375 |
Mar. 11 | 25.125 | May 2 | 37.875 |
Mar. 14 | 24.875 | May 3 | 38.375 |
Mar. 15 | 24.625 | May 4 | 38.375 |
Mar. 16 | 24.750 | May 5 | 38.000 |
Mar. 17 | 25.375 | May 6 | 38.250 |
Mar. 18 | 25.750 | May 9 | 38.750 |
Mar. 21 | 25.675 | May 10 | 38.125 |
Mar. 22 | 25.375 | May 11 | 37.125 |
Mar. 23 | 25.500 | May 12 | 37.000 |
Mar. 24 | 28.000 | May 13 | 36.875 |
Mar. 25 | 29.500 | May 16 | 36.500 |
Mar. 28 | 29.750 | May 17 | 36.250 |
Mar. 29 | 30.375 | May 18 | 36.250 |
Mar. 30 | 28.500 | May 19 | 36.250 |
Mar. 31 | 28.500 | May 20 | 36.250 |
Apr. 1 | 28.500 | May 23 | 36.250 |
Apr. 4 | 28.125 | May 24 | 36.250 |
Apr. 5 | 29.375 | May 25 | 36.250 |
Apr. 6 | 30.125 | May 26 | 36.250 |
Apr. 7 | 31.500 | May 27 | 36.375 |
Apr. 8 | 37.375 | May 30 | Holiday |
Apr. 11 | 36.750 | May 31 | 36.375 |
Apr. 12 | 36.750 | June 1 | 36.250 |
Apr. 13 | 36.500 | June 2 | 36.250 |
Apr. 14 | 35.750 | June 3 | 36.250 |
Apr. 15 | 34.875 | June 6 | 36.500 |
Apr. 18 | 36.125 | June 7 | 36.500 |
Apr. 19 | 35.750 |
105 T.C. 166">*210 COHEN, J., dissenting: As indicated in the majority opinion note 1, the facts stated in that opinion are those found by me as the trial judge. I respectfully dissent from the legal analysis and the result reached by the majority. I believe that the facts distinguish this case from
The distinguishing factual circumstances1995 U.S. Tax Ct. LEXIS 50">*138 herein are shown by a brief recapitulation of
In We base our holding upon1995 U.S. Tax Ct. LEXIS 50">*139 our judgment that petitioner's directors determined that it would be in petitioner's long-term interest to shift ownership of the corporate stock to Unilever. The expenditures in issue were incurred incident to that shift in ownership and, accordingly, lead [sic] to a benefit "which could be expected to produce returns for many years in the future." * * * The reason for the capitalization of such expenditures is "that
Our holding in
The Supreme Court granted certiorari, and, in courts more frequently have characterized an expenditure as capital in nature because "
With the foregoing rule in mind, the Supreme Court emphasized that the fees were capital expenditures because they were incurred for the purpose of facilitating a merger that created significant long-term benefits to National Starch. Citing statements in reports made by National Starch and its investment bankers, the Supreme Court held that the record supported our finding that the fees were incurred for the purpose of producing significant long-term benefits for National Starch as a result of the merger. The Supreme Court did not indicate in
In The Court, quoting
Following the analysis in
In contrast to the circumstances in
The parties disagree as to when the SCI board became subject to the duties discussed in
The only benefits to the future operations of petitioner discussed in the majority opinion are those perceived by the offeror, Tate & Lyle, and not by the management that incurred the expenses. The majority also states: "Positive consequences of a nonoperational nature resulting to SCI from the acquisition include a consolidation of stock ownership and relief from shareholder-related expenses and duties." Majority op. p. 25. The majority seems to believe that it is always better for a corporation to be privately held rather than publicly held--a questionable assumption considering this nation's economy.
In any event, the transformation from a publicly held corporation to1995 U.S. Tax Ct. LEXIS 50">*148 a wholly owned subsidiary was one of the results considered to be a significant benefit to the taxpayers in
Here, the record contains no evidence that the SCI management or board of directors thought or indicated that a combination with Tate & Lyle would produce any benefits for SCI. Instead, the record indicates that SCI management 105 T.C. 166">*216 believed that a Tate & Lyle takeover would not be in the best interests of SCI because Tate & Lyle had nothing to offer in terms of capital, marketing, or research and development and also because Tate & Lyle sought to abandon the SCI long-term strategic plan of diversifying into the food service business.
While petitioner has the burden of proving its right to the deduction in issue, Rule 142(a);
The majority disallows the deductions claimed under
105 T.C. 166">*217 I have other disagreements with assumptions made in the majority opinion and in Judge Beghe's concurring opinion. For example, there is the assertion that the fees paid to SCI's investment bankers necessarily increased the price of the stock. Majority op. p. 25. This analysis confuses the simple sequence of events with the purpose for which the expenditure was incurred, or the cause and effect relationship between an expenditure and a change in the price of the stock. The initial Tate & Lyle offer was $ 32 per share, about 15 percent or $ 5 less than the closing price of the1995 U.S. Tax Ct. LEXIS 50">*152 stock on the day bidding commenced. Tate & Lyle certainly had its own reasons for desiring the purchase and was independently evaluating the acquisition in relying on its own advisers. The Tate & Lyle decision to increase the price caused the expense of subsequent analysis on behalf of Staley and was not necessarily or even probably induced by the initial analysis provided to Staley's board. In any event, benefits to the
When it tried this case, petitioner had the benefit of the opinions of the Supreme Court in
CHABOT, JACOBS, CHIECHI, and LARO,
105 T.C. 166">*218 LARO,
The Supreme Court in
105 T.C. 166">*219 In
The majority opinion1995 U.S. Tax Ct. LEXIS 50">*156 identifies no specific long-term benefits to SCI from the takeover that could account for the SCI board's decision to abandon its resistance.
The majority suggests that since the "directors approved the takeover, they must have determined that it was in the best interest of [the company] and its shareholders". However, the majority does not identify any significant benefit to SCI to conclude that indeed it was in the best interest of SCI for the takeover to occur. It would be erroneous to conclude that a benefit is achieved merely by taking a public company private. In some instances, such a transaction is beneficial but in other instances it is not. A private company does not have access to the public markets for new capital and does not have the same liquidity for its shareholders. One cannot accurately conclude, therefore, that a hostile takeover resulting in a public company's going private produces in and of itself a long-term benefit.
It would be wrong to suggest that merely because a takeover is hostile, rather than friendly, the expenses incurred in connection therewith should be deductible. However, a complete legal analysis would address the issue as to whether or not 1995 U.S. Tax Ct. LEXIS 50">*157 the takeover was hostile or friendly for the purpose of seeing whether there were any long-term benefits in connection with the transaction. Having found facts to conclude that the takeover is hostile, one should strongly suspect that there are no long-term benefits anticipated by the target in connection with the transaction. 1 Yet the majority opinion 105 T.C. 166">*220 seems to dismiss the fact that the takeover involved in this case was hostile as a relevant factor.
Under
The majority opinion also does not distinguish successfully the recent District Court case of
CHABOT and JACOBS,
1. The trial portion of this case was conducted by Judge Mary Ann Cohen, and the facts are as found by Judge Cohen↩.
2. Respondent's statutory notice of deficiency also disallowed about 12 percent of the legal fee charged by Skadden, Arps, Slate, Meagher & Flom (Skadden Arps) ($ 649,815 out of $ 7,581,171). Petitioner did not contest that disallowance, and respondent, although asserting in her trial memorandum that the Skadden Arps' fee should have been disallowed in its entirety, did not seek an increased deficiency.↩
3. We say that for the following reasons:
RP Acquisition was funded with $ 1,453,000,000 for purposes of acquiring shares of Staley Continental, Inc. and Subsidiaries (SCI). Disregarding any transaction costs of RP Acquisition, 4 percent of that amount was returned to Tate & Lyle in respect of its preexisting stock interest in SCI, reducing the amount paid to other shareholders of SCI to $ 1,394,880,000. The offering price in the initial tender offer, rejected as inadequate with the investment bankers' advice, was $ 32 a share, increased to $ 35, again rejected as inadequate with the investment bankers' advice, and finally accepted as in the best interests of the shareholders, again with the investment bankers' advice, at $ 36.50 a share. That means that $ 4.50 a share, approximately 12 percent of the total of $ 36.50 a share ultimately paid for the SCI stock, represents the increase in price arguably obtained with the help of the investment bankers. Extending that computation to the full $ 1,394,880,000 paid for all of the non-Tate & Lyle-held SCI shares, there was a price increase of approximately $ 167 million. That compares with the approximately $ 12.5 million of fees paid to the investment bankers pursuant to the April 12 retainer agreements. Pursuant to those agreements, some substantial part of the investment bankers' work necessarily was devoted to evaluating SCI's share value in relation to the various offers, with the remainder apparently devoted to advising and assisting the board with regard to defending against the Tate & Lyle takeover. We have no doubt that the board relied on the advice of the investment bankers in deciding, first, to reject and, ultimately, to accept an offer by Tate & Lyle. It is no more than common sense that Tate & Lyle's first increase in the amount of its offer was at least in part due to the board's rejection of its initial offer. Whether the investment bankers' search for a white knight, or other assistance in mounting a defense, accounted for Tate & Lyle's raising its offer in any amount is unknown, although it is not improbable. Certainly, at least some of the investment bankers' defensive work helped the investment bankers advise the board on May 10, 1988, that no better deal could be found.
We cannot escape the conclusion that there was a direct connection between the work of the investment bankers pursuant to the April 12 retainer agreements and the $ 4.50 increase from Tate & Lyle's first offer of $ 32 to Tate & Lyle's third offer of $ 36.50 made on May 13, 1988. Accordingly, we conclude that, in consideration of payments of approximately $ 12.5 million made pursuant to the April 12 retainer agreements, the investment bankers rendered services to SCI that substantially increased the amount realized by SCI shareholders in connection with a sale of their stock to RP Acquisition.↩
1. The most important ancillary tax consequence of adopting the alternative theory of disallowance suggested in this concurring opinion is that the disallowed amount would not appear on the tax balance sheet as capital expenditures that might be deductible at some later time, such as the payor's liquidation.
2. See majority op. note 3 and pp. 25-26; pp. 37-40.↩
3. See, e.g., Johnson, "The Expenditures Incurred by the Target Corporation in an Acquisitive Reorganization Are Dividends to the Shareholders (Psst, Don't Tell the Supreme Court)",
4. See Appendix,
5. See
6.
7. Compare
8. The approach suggested here would be consistent with the observation in Bittker & Eustice, Federal Income Taxation of Corporations and Shareholders, par. 7.05, at 7-33 (4th ed. 1979), that the Service was often content to disallow deduction of constructive dividends at the corporate level without coupling the disallowance with a deficiency determination based upon a dividend income inclusion to the shareholders. But see
9. The fact that an expense was not an ordinary and necessary business expense of a corporation does not unerringly point to the conclusion that the expense was a personal expense of the corporation's stockholders. An expense might be a capital expense to a corporation, or a non-allowable expense of a corporation, and still not be a personal expense of the corporation's stockholders. [
The taxpayer before the District Court in Thus, the Court concludes that the payment was not payment of a personal expense of taxpayers or taxpayer-husband, but was a payment for the benefit of Cloverdale and serving its legitimate corporate business purpose,
10. For an accurate and useful summary of the facts of these cases and of the opinions of the bankruptcy judge and the District Court, see Lipton & Brenneman, "Expenses Related to Failed Merger Defense Held to Be Deductible Despite
11. The alternative holding in
1. "Some circumstantial evidence is very strong, as when you find a trout in the milk." Bartlett, Familiar Quotations 557 (15th ed. 1980).↩